Sign in

CIK 0001635088 · Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
operating
EIN
981173944
Phone
441-295-5950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
  1. SC 13G Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Material agreement · Results of operations · Unregistered share sale
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. EFFECT Other Notice of Effectiveness
  8. 424B3 Offering Prospectus
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. UPLOAD Other SEC-generated Letter
  11. S-1 Offering Registration Statement
  12. 424B3 Offering Prospectus
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. EFFECT Other Notice of Effectiveness
  16. 424B3 Offering Prospectus
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. UPLOAD Other SEC-generated Letter
  19. S-1 Offering Registration Statement
  20. 4 Insider Changes in Ownership

Page 44 of 51 · 1,008 filings